news - International Biopharmaceutical Industry

Current Edition

news

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of...

11 May 2018 news Expand | Merck

Continue Reading →

news

Biopharmaceuticals Market Strongly guided by Companies like ABBVIE, AMGEN, BRISTOL

The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological adva...

11 May 2018 news ABBVIE | biopharmaceutical

Continue Reading →

news

Putting the Technicals Into Perspective For Sino Biopharmaceutical ADR (SBHMY)

Investors have placed Sino Biopharmaceutical ADR (SBHMY) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward momentum...

11 May 2018 news ADR | biopharmaceutical

Continue Reading →

news

Takeda to Acquire Shire for $62 Billion

Takeda Pharmaceutical Company Limited announced on May 8, 2018 that it has reached agreement on the terms of an offer to acquire Shire plc in a deal valued at $62 bil...

11 May 2018 news 62 | Acquire

Continue Reading →

news

Lilly strikes $1.6B deal to buy I-O player Armo Biosciences

Eli Lilly and Co. said it will buy Armo Biosciences Inc. for about $1.6 billion, in an all-cash transaction intended to bolster its immuno-oncology program through th...

11 May 2018 news 1.6B | Armo

Continue Reading →

news

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Over the past seven years, Samsung BioLogics has constructed three state-of-the-art production facilities offering end-to-end integrated services to support the rapid...

8 May 2018 news biologics | development

Continue Reading →

news

Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development

Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the dev...

8 May 2018 news Abcam | alliance

Continue Reading →

news

Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to esta...

8 May 2018 news AG | Brunswieck

Continue Reading →

news

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies an...

4 May 2018 news achieving | cell

Continue Reading →

news

The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories

On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. S...

4 May 2018 news Achievments | Association

Continue Reading →